NASDAQ

RenovoRx Inc

1.27
前日比
+0.06(+4.96%)
RNXT医療関連
  • 15分ディレイ株価

RenovoRx Incの企業情報(従業員数・代表者名など)

企業情報

特色

RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for its lead product candidate RenovoGem™. Co.'s therapy platform, RenovoRx Trans-Arterial Micro-Perfusion, or RenovoTAMP™ utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening thei

英文社名

RenovoRx Inc

本社所在地

4546 El Camino Real, Suite B1 Los Altos, CA 94022 USA

電話番号

650 284-4433

設立年月

---

代表者名

---

業種名

医療関連(Health Care)

市場名

---

従業員数

---

ウェブサイト

www.renovorx.com